Replies to post #227664 on Biotech Values

[BioBS2012]

Nope, not comparable agreed. One has outcomes data, the other does not !!
One is approved and selling over $400 mm with an expanded label in hand, the other still has some time before it gets approved.

[north40000]

I have not followed MedCo. Why do you opine that it has better, stronger and longer-lived IP than Amarin?